The healthcare event SEACare 2024 provided a platform for global healthcare and pharmaceutical players to showcase their latest products and innovations while aiming to establish strategic partnerships with local and regional industries. It presented a unique opportunity for local healthcare players to enhance their brand recognition and effectively promote
their products and services, particularly to the Southeast Asia market.
During the event here recently, eight international buyers from Thailand, Vietnam, UAE, Zambia, and Zimbabwe participated in the INSPand were matched with 30 Malaysian companies in 95 pre- arranged business meetings. This programme led to potential sales totalling RM28.65 million. Among Malaysian products that received great interests were essential medical supplies like syringes, needles, blood collection tubes and latex-free tourniquets.
According to MATRADE’s CEO, Datuk Mohd Mustafa Abdul Aziz, “MATRADE is committed to strengthening Malaysia’s healthcare product exports by enhancing the capability of our industry players. The strategic collaboration with SEACare
exemplifies the benefits enjoyed by Malaysian healthcare businesses from such an initiative that helps them increase international sales”.
Malaysia’s total trade for medical devices and pharmaceuticals rose to reach RM14.08 billion in the first quarter of 2024, compared to the same period in 2023, which was RM12.4 billion.
Malaysia’s exports of medical devices and pharmaceuticals recorded a 16% growth to RM8.93 billion in the first quarter of 2024, compared to RM7.70 billion in the corresponding period of 2023. Imports, on the other hand were valued at RM5.15
billion, reflecting a 10% increase from RM4.70 billion recorded in 2023.
